Cargando…

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma with variable clinical outcomes and prediction of prognosis remains important for long-term remission. We performed serial serum soluble interleukin-2 receptor (sIL-2R) measurement pretreatment and before each cycle of the treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Yu-Jia, Xu, Peng-Peng, Wang, Li, Zhong, Hui-Juan, Fu, Di, Shi, Qing, Cheng, Shu, Wang, Shuo, Zhang, Mu-Chen, Zhao, Wei-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316360/ https://www.ncbi.nlm.nih.gov/pubmed/35879731 http://dx.doi.org/10.1186/s40364-022-00401-4

Ejemplares similares

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B‐cell lymphoma
por: Shen, Rong, et al.
Publicado: (2020)

Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma
por: Zhu, Yue, et al.
Publicado: (2022)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

An 11 years delayed diagnosis of primary pulmonary diffuse large B cell lymphoma
por: Yu, Jin-Yan, et al.
Publicado: (2019)

Identification of prognostic genes in lung adenocarcinoma immune microenvironment
por: Han, Lian-Kui, et al.
Publicado: (2021)

Neurolymphomatosis caused by diffuse large B-cell lymphoma presenting as isolated brachial plexopathy
por: Li, Heng, et al.
Publicado: (2019)

Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways
por: Willemsen, Mathijs, et al.
Publicado: (2018)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress
por: Liu, Shu-Zhong, et al.
Publicado: (2018)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
por: Jain, Preetesh, et al.
Publicado: (2023)

Glofitamab therapy for diffuse large B cell lymphoma: latest updates from the 2022 ASH Annual Meeting
por: Wang, Chaoyu, et al.
Publicado: (2023)

Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
por: Wu, Shaohua, et al.
Publicado: (2017)

Systemic diffuse large B-cell lymphoma with bilateral ciliary body involvement
por: Di, Yu, et al.
Publicado: (2020)

Guillain-Barre Syndrome Complicated on Postoperation on Renal Carcinoma and Meningioma
por: Xu, Shuai, et al.
Publicado: (2018)

Systemic lupus erythematosus with diffuse alveolar hemorrhage
por: Huo, Rongxiu, et al.
Publicado: (2023)

Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors
por: Lu, Li, et al.
Publicado: (2019)

Design Flaws in the Study of Distinguishing Diabetes Associated With Chronic Pancreatitis and Type 2 Diabetes Mellitus
por: Liu, Yu, et al.
Publicado: (2019)

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
por: El-Sharkawi, Dima, et al.
Publicado: (2023)

Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering
por: Zhang, Wei, et al.
Publicado: (2007)

Clinical and prognostic features of primary retroperitoneal diffuse large B-cell lymphoma: a single-center experience in China
por: Liu, Xiao-Hong, et al.
Publicado: (2021)

Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry
por: Liu, Long, et al.
Publicado: (2022)

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
por: Tanba, Kazuna, et al.
Publicado: (2018)

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients
por: Manfroi, B., et al.
Publicado: (2018)

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
por: Mangano, Chiara, et al.
Publicado: (2019)

The Solubility of Quinoidine
por: Waters, E. E.
Publicado: (1916)

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
por: Al-Sarayfi, Diana, et al.
Publicado: (2022)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Targeting Bruton’s tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study
por: Guan, Wenxue, et al.
Publicado: (2022)

An immunopathogenic perspective of interleukin-1 signaling
por: Lin, Xinwen, et al.
Publicado: (2020)

Metatranscriptomics of Nasopharyngeal Microbiota and Host Distinguish between Pneumonia and Health
por: Nannapaneni, Priyanka, et al.
Publicado: (2022)

Primary Small Intestinal Diffuse Large B-cell Lymphoma Masquerading as Crohn's Disease: A Case Report
por: Lu, Xiao-Hong, et al.
Publicado: (2017)

Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma
por: Guidez, Stephanie, et al.
Publicado: (2019)

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Surgical Treatment of Malignant Pheochromocytomas in Spine
por: Liu, Shu-Zhong, et al.
Publicado: (2018)

Tumor-induced osteomalacia caused by a phosphaturic mesenchymal tumor of the femur
por: Liu, Shu-Zhong, et al.
Publicado: (2019)

CD23 mediated the induction of pro-inflammatory cytokines Interleukin-1 beta and tumor necrosis factors-alpha in Aspergillus fumigatus keratitis
por: Yan, Hai-Jing, et al.
Publicado: (2021)

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
por: Richter, Julia, et al.
Publicado: (2019)

Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas
por: Sha, Chulin, et al.
Publicado: (2015)

PAX8 Distinguishes Diffuse Large B-Cell Lymphoma Mimicking Sarcoma
por: Hirsch, Michelle S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kg4bs4a8bl5dk42antesklvnkb